Galapagos NV
GLPG
#4540
Rank
S$2.84 B
Marketcap
S$43.10
Share price
-0.73%
Change (1 day)
36.95%
Change (1 year)

EPS for Galapagos NV (GLPG)

EPS in 2025 (TTM): S-$0.42

According to Galapagos NV's latest financial reports the company's current EPS (TTM) is S-$0.43. In 2024 the company made an earnings per share (EPS) of S$1.48 a decrease over its 2023 EPS that were of S$4.51.

EPS history for Galapagos NV from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S-$0.42-128.62%
2024S$1.48-67.16%
2023S$4.51-199.64%
2022S-$4.5399.03%
2021S-$2.28-68.98%
2020S-$7.34-298.06%
2019S$3.71-554.64%
2018S-$0.81-77.18%
2017S-$3.57-326.21%
2016S$1.58-134.19%
2015S-$4.62-371.34%
2014S$1.70-445.98%
2013S-$0.4932.88%
2012S-$0.37-82.07%
2011S-$2.07-817.9%
2010S$0.2912.73%
2009S$0.26-120.79%
2008S-$1.23-37.67%
2007S-$1.9739.64%
2006S-$1.4128.17%
2005S-$1.106.25%
2004S-$1.04

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$13.28-3,178.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$10.25-2,475.89%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$1.72-498.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$4.71-1,192.75%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
S$9.66-2,339.29%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$3.86-994.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
S$4.57-1,160.38%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
S-$0.78 79.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$0.80-285.78%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel